Summary Each year, the American Heart Association (AHA), in conjunction with the Centers
for Disease Control and Prevention, the National Institutes of Health, and other government …

(CVD) in individuals with type 1 diabetes mellitus (T1DM), the pathophysiology underlying
the relationship between cardiovascular events, CVD risk factors, and T1DM is not well …

Background People with type 1 diabetes are at elevated risk of mortality and cardiovascular
disease, yet current guidelines do not consider age of onset as an important risk stratifier …

Background Long-term trends in excess risk of death and cardiovascular outcomes have not
been extensively studied in persons with type 1 diabetes or type 2 diabetes. Methods We …

Summary Each year, the American Heart Association (AHA), in conjunction with the Centers
for Disease Control and Prevention, the National Institutes of Health, and other government …

Background The excess risk of death from any cause and of death from cardiovascular
causes is unknown among patients with type 1 diabetes and various levels of glycemic …

Summary Each year, the American Heart Association (AHA), in conjunction with the Centers
for Disease Control and Prevention, the National Institutes of Health, and other government …

Objective To investigate the long term effects of continuous subcutaneous insulin infusion
(insulin pump therapy) on cardiovascular diseases and mortality in people with type 1 …

Objective To evaluate if the lowest target level for glycated haemoglobin (HbA 1c) of< 6.5%
is associated with lower risk for retinopathy and nephropathy than less tight control in …

Background Poor glycaemic control is associated with microvascular and macrovascular
complications in type 1 diabetes, but whether glycaemic control is associated with heart …